We are live on ! Find out more
LPA

Lansdowne Partners Austria Portfolio holdings

AUM $29M
1-Year Est. Return 40.34%
This Fund
S&P 500
This Quarter Est. Return
-1.81%
1 Year Est. Return
-40.34%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.26M
AUM Growth
–
Cap. Flow
+$5.5M
Cap. Flow %
104.43%
Top 10 Hldgs %
100%
Holding
1
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
ALXA
Alexza Pharmaceuticals Inc
ALXA
+$5.5M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALXA
1
DELISTED
Alexza Pharmaceuticals Inc
ALXA
$5.26M 100%
+1,212,555
New +$5.5M

Similar funds

MC
MSF Capital New York $30.3M AUM 4.9% 1-Year Est. Return
LCM
LG Capital Management Owings Mills, Maryland $31.7M AUM 28.49% 1-Year Est. Return
KP
Kiski Partners New York $26.1M AUM
BPAMSD
BTG Pactual Asset Management SA DTVM Sao Paulo, Brazil $25.4M AUM
IEMC
Insight Equity Management Company Southlake, Texas $33.2M AUM 91.43% 1-Year Est. Return
NC
Nevsky Capital London, United Kingdom $33.4M AUM 3.39% 1-Year Est. Return
SIS
Sandell Investment Services New York $23.2M AUM 7.13% 1-Year Est. Return
FIG
Fusion Investment Group Pittsburgh, Pennsylvania $37.3M AUM 3.34% 1-Year Est. Return

Lansdowne Partners Austria's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Lansdowne Partners Austria, which disclosed 1 position worth $5.26M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Alexza Pharmaceuticals Inc: 1,212,555 shares worth $5.26M.

  • Lansdowne Partners Austria's largest Q2 2013 buy was Alexza Pharmaceuticals Inc: 1,212,555 shares worth $5.26M.
  • Lansdowne Partners Austria's ten largest holdings make up 100% of its $5.26M portfolio in Q2 2013.
  • Lansdowne Partners Austria disclosed 1 position in Q2 2013, its first 13F filing on record.

Based on Lansdowne Partners Austria's 13F filing for Q2 2013, filed 14 Aug 2013.